Skip to main content

Breadcrumb

  1. Home

Maintenance

Ischemic Vascular Disease (IVD): Blood Pressure Control

  • The percentage of patients 18 to 75 years of age who were discharged alive with acute myocardial infarction (AMI), coronary artery bypass graft (CABG) or percutaneous coronary interventions (PCI) during the 12 months prior to the measurement year, or who had a diagnosis of ischemic vascular disease (IVD) during the measurement year and the year prior to the measurement year and who had the following during the measurement year:

    - Blood pressure control (BP): reported as under control <140/90 mm Hg.

    CBE ID
    0073

Ischemic Vascular Disease (IVD): Complete Lipid Profile and LDL-C Control &lt;100 mg/dL

  • The percentage of patients 18 years of age and older who were discharged alive for acute myocardial infarction (AMI), coronary artery bypass graft (CABG) or percutaneous coronary interventions (PCI) during the 12 months prior to the measurement year, or who had a diagnosis of ischemic vascular disease (IVD) during the measurement year and the year prior to measurement year, who had each of the following during the measurement year.

    - Complete Lipid Profile
    - LDL-C control <100 mg/dL

    CBE ID
    0075

Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antiplatelet

  • The percentage of patients 18 years of age and older who were discharged from an inpatient setting with an acute myocardial infarction (AMI), coronary artery bypass graft (CABG) or percutaneous coronary intervention (PCI) during the 12 months prior to the measurement year, or who had a diagnosis of ischemic vascular disease (IVD) during the measurement year and the year prior to the measurement year and who had documentation of routine use of aspirin or another antiplatelet during the measurement year.

    CBE ID
    0068

Knee Arthroplasty

  • The Knee Arthroplasty cost measure evaluates clinicians’ risk-adjusted cost to Medicare for beneficiaries who receive this procedure. The cost measure score is a clinician’s average risk-adjusted cost for the episode group averaged across all episodes attributed to the clinician. This procedural measure includes costs of services that are clinically related to the attributed clinician’s role in managing care during the 30 days prior to the clinical event that opens or ‘triggers’ the episode, through 90 days after the trigger.

    CBE ID
    3512

Laboratory Investigation for Secondary Causes of Fracture

  • Percentage of patients age 50 and over with fragility fracture who have had appropriate laboratory investigation for secondary causes of fracture ordered or performed prior to discharge from inpatient status.

    CBE ID
    2416

Late HIV diagnosis

  • Percentage of persons 13 years and older diagnosed with Stage 3 HIV infection (AIDS) within 3 months of a diagnosis of HIV infection.

    CBE ID
    1999